These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


238 related items for PubMed ID: 19834041

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Specific deficits in visual electrophysiology in a mouse model of dominant optic atrophy.
    Barnard AR, Charbel Issa P, Perganta G, Williams PA, Davies VJ, Sekaran S, Votruba M, MacLaren RE.
    Exp Eye Res; 2011 Nov; 93(5):771-7. PubMed ID: 21803037
    [Abstract] [Full Text] [Related]

  • 3. A splice site mutation in the murine Opa1 gene features pathology of autosomal dominant optic atrophy.
    Alavi MV, Bette S, Schimpf S, Schuettauf F, Schraermeyer U, Wehrl HF, Ruttiger L, Beck SC, Tonagel F, Pichler BJ, Knipper M, Peters T, Laufs J, Wissinger B.
    Brain; 2007 Apr; 130(Pt 4):1029-42. PubMed ID: 17314202
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Reduction of oscillatory potentials and photopic negative response in patients with autosomal dominant optic atrophy with OPA1 mutations.
    Miyata K, Nakamura M, Kondo M, Lin J, Ueno S, Miyake Y, Terasaki H.
    Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):820-4. PubMed ID: 17251483
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Opa1 deficiency in a mouse model of autosomal dominant optic atrophy impairs mitochondrial morphology, optic nerve structure and visual function.
    Davies VJ, Hollins AJ, Piechota MJ, Yip W, Davies JR, White KE, Nicols PP, Boulton ME, Votruba M.
    Hum Mol Genet; 2007 Jun 01; 16(11):1307-18. PubMed ID: 17428816
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Opa1 deficiency in a mouse model of dominant optic atrophy leads to retinal ganglion cell dendropathy.
    Williams PA, Morgan JE, Votruba M.
    Brain; 2010 Oct 01; 133(10):2942-51. PubMed ID: 20817698
    [Abstract] [Full Text] [Related]

  • 14. Increased steroidogenesis promotes early-onset and severe vision loss in females with OPA1 dominant optic atrophy.
    Sarzi E, Seveno M, Angebault C, Milea D, Rönnbäck C, Quilès M, Adrian M, Grenier J, Caignard A, Lacroux A, Lavergne C, Reynier P, Larsen M, Hamel CP, Delettre C, Lenaers G, Müller A.
    Hum Mol Genet; 2016 Jun 15; 25(12):2539-2551. PubMed ID: 27260406
    [Abstract] [Full Text] [Related]

  • 15. Correlation between visual acuity and OCT-measured retinal nerve fiber layer thickness in a family with ADOA and an OPA1 mutation.
    Russo A, Delcassi L, Marchina E, Semeraro F.
    Ophthalmic Genet; 2013 Jun 15; 34(1-2):69-74. PubMed ID: 22779427
    [Abstract] [Full Text] [Related]

  • 16. Electrophysiology and ocular blood flow in a family with dominant optic nerve atrophy and a mutation in the OPA1 gene.
    Gränse L, Bergstrand I, Thiselton D, Ponjavic V, Heijl A, Votruba M, Andréasson S.
    Ophthalmic Genet; 2003 Dec 15; 24(4):233-45. PubMed ID: 14566653
    [Abstract] [Full Text] [Related]

  • 17. Electrophysiological ON and OFF Responses in Autosomal Dominant Optic Atrophy.
    Morny EK, Margrain TH, Binns AM, Votruba M.
    Invest Ophthalmol Vis Sci; 2015 Dec 15; 56(13):7629-37. PubMed ID: 26624494
    [Abstract] [Full Text] [Related]

  • 18. Genotype-phenotype heterogeneity of ganglion cell and inner plexiform layer deficit in autosomal-dominant optic atrophy.
    Rönnbäck C, Nissen C, Almind GJ, Grønskov K, Milea D, Larsen M.
    Acta Ophthalmol; 2015 Dec 15; 93(8):762-6. PubMed ID: 26385429
    [Abstract] [Full Text] [Related]

  • 19. A randomized, placebo-controlled trial of the benzoquinone idebenone in a mouse model of OPA1-related dominant optic atrophy reveals a limited therapeutic effect on retinal ganglion cell dendropathy and visual function.
    Smith TG, Seto S, Ganne P, Votruba M.
    Neuroscience; 2016 Apr 05; 319():92-106. PubMed ID: 26820596
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.